Connection

Swapan Ray to Neuroprotective Agents

Back to Details
This is a "connection" page, showing publications Swapan Ray has written about Neuroprotective Agents.
Swapan Ray
Connection Strength
2.968
Neuroprotective Agents
  1. Molecular mechanisms of estrogen for neuroprotection in spinal cord injury and traumatic brain injury. Rev Neurosci. 2016 04 01; 27(3):271-81.
    View in: PubMed
    Score: 0.428
  2. Experimental Procedures for Demonstration of MicroRNA Mediated Enhancement of Functional Neuroprotective Effects of Estrogen Receptor Agonists. Methods Mol Biol. 2016; 1366:359-372.
    View in: PubMed
    Score: 0.421
  3. Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration. Brain Res Bull. 2014 Oct; 109:22-31.
    View in: PubMed
    Score: 0.385
  4. Direct evidence for calpain involvement in apoptotic death of neurons in spinal cord injury in rats and neuroprotection with calpain inhibitor. Neurochem Res. 2007 Dec; 32(12):2210-6.
    View in: PubMed
    Score: 0.235
  5. Calpeptin provides functional neuroprotection to rat retinal ganglion cells following Ca2+ influx. Brain Res. 2006 Apr 21; 1084(1):146-57.
    View in: PubMed
    Score: 0.214
  6. Currently evaluated calpain and caspase inhibitors for neuroprotection in experimental brain ischemia. Curr Med Chem. 2006; 13(28):3425-40.
    View in: PubMed
    Score: 0.210
  7. Calpain activation in apoptosis of ventral spinal cord 4.1 (VSC4.1) motoneurons exposed to glutamate: calpain inhibition provides functional neuroprotection. J Neurosci Res. 2005 Aug 15; 81(4):551-62.
    View in: PubMed
    Score: 0.205
  8. Calpain inhibition reduces structural and functional impairment of retinal ganglion cells in experimental optic neuritis. J Neurochem. 2016 10; 139(2):270-284.
    View in: PubMed
    Score: 0.111
  9. Neuroprotective effects of genistein in VSC4.1 motoneurons exposed to activated microglial cytokines. Neurochem Int. 2011 Aug; 59(2):175-84.
    View in: PubMed
    Score: 0.077
  10. Inhibition of cysteine proteases in acute and chronic spinal cord injury. Neurotherapeutics. 2011 Apr; 8(2):180-6.
    View in: PubMed
    Score: 0.076
  11. Physiological low dose of estrogen-protected neurons in experimental spinal cord injury. Ann N Y Acad Sci. 2010 Jun; 1199:86-9.
    View in: PubMed
    Score: 0.071
  12. Neuroprotective efficacy of estrogen in experimental spinal cord injury in rats. Ann N Y Acad Sci. 2010 Jun; 1199:90-4.
    View in: PubMed
    Score: 0.071
  13. Therapeutic potential of melatonin in traumatic central nervous system injury. J Pineal Res. 2009 Sep; 47(2):134-142.
    View in: PubMed
    Score: 0.067
  14. Estrogen attenuates glutamate-induced cell death by inhibiting Ca2+ influx through L-type voltage-gated Ca2+ channels. Brain Res. 2009 Jun 18; 1276:159-70.
    View in: PubMed
    Score: 0.066
  15. Melatonin attenuates calpain upregulation, axonal damage and neuronal death in spinal cord injury in rats. J Pineal Res. 2008 May; 44(4):348-57.
    View in: PubMed
    Score: 0.060
  16. Estrogen as a multi-active neuroprotective agent in traumatic injuries. Neurochem Res. 2004 Nov; 29(11):2007-14.
    View in: PubMed
    Score: 0.049
  17. Estrogen as a neuroprotective agent in the treatment of spinal cord injury. Ann N Y Acad Sci. 2003 May; 993:125-33; discussion 159-60.
    View in: PubMed
    Score: 0.044
  18. Cell-Permeable Calpain Inhibitor SJA6017 Provides Functional Protection to Spinal Motoneurons Exposed to MPP. Neurotox Res. 2020 Oct; 38(3):640-649.
    View in: PubMed
    Score: 0.036
  19. Neuron-microglia interaction induced bi-directional cytotoxicity associated with calpain activation. J Neurochem. 2016 11; 139(3):440-455.
    View in: PubMed
    Score: 0.028
  20. Administration of low dose estrogen attenuates gliosis and protects neurons in acute spinal cord injury in rats. J Neurochem. 2016 Mar; 136(5):1064-73.
    View in: PubMed
    Score: 0.026
  21. Overexpression of melatonin membrane receptors increases calcium-binding proteins and protects VSC4.1 motoneurons from glutamate toxicity through multiple mechanisms. J Pineal Res. 2013 Jan; 54(1):58-68.
    View in: PubMed
    Score: 0.021
  22. Low dose estrogen prevents neuronal degeneration and microglial reactivity in an acute model of spinal cord injury: effect of dosing, route of administration, and therapy delay. Neurochem Res. 2011 Oct; 36(10):1809-16.
    View in: PubMed
    Score: 0.019
  23. Estrogen receptor agonists and estrogen attenuate TNF-a-induced apoptosis in VSC4.1 motoneurons. J Endocrinol. 2011 Feb; 208(2):171-82.
    View in: PubMed
    Score: 0.018
  24. Extranigral neurodegeneration in Parkinson's disease. Ann N Y Acad Sci. 2008 Oct; 1139:331-6.
    View in: PubMed
    Score: 0.016
  25. Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res. 2005 Oct 15; 82(2):283-93.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.